Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2012.00009
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Cell-Cycle Checkpoints and Aneuploidy on the Path to Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

TRPA1 Channels as Novel Molecular Targets for Anti-Inflammatory Therapies in CF Lung

Postdoc Journal
2016English

Anti‐angiogenic Therapies for Gastric Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of P53-Defective Tumors to Chemotherapy

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Understanding the Limitations of Radiation-Induced Cell Cycle Checkpoints

Critical Reviews in Biochemistry and Molecular Biology
BiochemistryMolecular Biology
2011English

The Nature of Cell-Cycle Checkpoints: Facts and Fallacies

Journal of Biology
2009English

Regulation of Cell Cycle Checkpoints by Polo-Like Kinases

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Novel Anti-Cancer Compounds Targeting the Cell Cycle

Folia Pharmacologica Japonica
Pharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy